Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Syntone Ventures LLC
10% owner at Outlook Therapeutics. Filing since 15 Jul 2020.
CIK 0001814394
Company
Date
Role
Action
Shares
Amount
Of holding
OTLK
Outlook Therapeutics, Inc.
15 Apr 2024
10% owner
Bought
714,286
no price
72.1%
OTLK
Outlook Therapeutics, Inc.
3 Feb 2021
10% owner
Bought
3,000,000
$3.00M
17.8%
OTLK
Outlook Therapeutics, Inc.
15 Jul 2020
10% owner
Bought
823,045
$1,000.00K
5.1%
3 decisions on file.
